Blood cancers

Study reveals impact of cancer-related cognitive decline in lymphoma patients

Chemo brain isn’t just for solid tumour patients: new evidence reinforces that lymphoma patients can experience cognitive impairment from up to six months post-treatment and possibly beyond. An American study compared cognitive function in 248 lymphoma patients from pre- to post-treatment and pre-treatment to six-months follow-up against that of 212 age- and gender-matched controls. It ...

Already a member?

Login to keep reading.

© 2021 the limbic